Phospho-Cyclin D1 (Thr286) Antibody

About the Target

CCND1 is a target of interest in many antibody-based workflows. Cyclin D1 is primarily recognized for its nuclear role in regulating cell cycle progression. It controls the transition from the G1 to S phase by acting as an allosteric regulator of cyclin-dependent kinases 4 (CDK4) and 6 (CDK6). The activated Cyclin D1/CDK4 complex translocates to the nucleus, where it phosphorylates the retinoblastoma (RB) protein in conjunction with Cyclin E/CDK2, thereby relieving RB’s inhibitory effect on the E2F transcription factor. Depending on the literature source, CCND1 may also be discussed as Phospho-Cyclin D1 (Thr286).

Reported cellular context includes cytoplasm, membrane, and nucleus, which can matter when signal is compared across treatments or changing cell states. Following CCND1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CCND1 is commonly interpreted in the context of cancer, cell cycle, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, membrane, and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm, membrane, and nucleus across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• cell-cycle linked differences in abundance, timing, or compartmental enrichment
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CCND1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CCND1 reflect biology rather than handling. When interpreting CCND1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CCND1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.